Order Article Reprints

Sorroche BP, Teixeira RdJ, Pereira CAD, Santana IVV, Vujanovic L, Vazquez VdL, Arantes LMRB. PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors’ Response and Survival in Advanced Melanoma Patients in Brazil. Diagnostics. 2023; 13(6):1041. https://doi.org/10.3390/diagnostics13061041

Sorroche, Bruna Pereira, Renan de Jesus Teixeira, Caio Augusto Dantas Pereira, Iara Viana Vidigal Santana, Lazar Vujanovic, Vinicius de Lima Vazquez, and Lidia Maria Rebolho Batista Arantes. 2023. "PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors’ Response and Survival in Advanced Melanoma Patients in Brazil" Diagnostics 13, no. 6: 1041. https://doi.org/10.3390/diagnostics13061041

Sorroche, B. P., Teixeira, R. d. J., Pereira, C. A. D., Santana, I. V. V., Vujanovic, L., Vazquez, V. d. L., & Arantes, L. M. R. B. (2023). PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors’ Response and Survival in Advanced Melanoma Patients in Brazil. Diagnostics, 13(6), 1041. https://doi.org/10.3390/diagnostics13061041